|
|
The 5th Annual Pharmacovigilance Conference is a prominent pharma event in United Kingdom that will focus on the key challenges for efficient implementation of pharmacovigilance in drug development. The conference, with the theme “Implementing best practices in drug safety and surveillance” will forward a crucial forum, to discuss raising issues and investigate various processes and developments on many different elements, including the regulatory and legislative framework, risk management, PSUR, live licensing, in drug safety and surveillance. It will feature latest insights, integrated strategies and best practices in pharmacovigilance. The 5th Annual Pharmacovigilance Conference will also enable the delegates to acquire knowledge on a number of issues, like Evaluation of risk mitigation activities: REMS and beyond from the pharmacoepidemiologist's perspective, Pharmacovigilance in clinical trials of investigational medicinal products, Implementing inspection readiness program as a guide to maximise readiness, etc.
Visitor Profile
The targeted visitors at the 5th Annual Pharmacovigilance Conference 2010 are VP’s, Directors, Heads, Managers, Scientific Advisors, and Consultants of:
- Pharmacovigilance
- Pharmacoepidemiology
- Pharmacogenomics
- Drug/Product Safety
- Drug Development
- Information and Clinical Data Management
- Clinical Pharmacology
- Clinical Safety
- PSUR
- Risk Management
- Research & Development
- Quality Assurance
- QPPV
- Patient Safety/ Surveillance
- Signal Detection
- Outcomes Research
- Data Analysis
- Epidemiology
- Toxicology
- Medical Affairs
- Regulatory Affairs and Compliance
- Sales & Marketing
Organizer
Visiongain Ltd.
